Results 111 to 120 of about 57,246 (250)

Health and Survival Impacts of Early Childhood Development Programmes: The Case of the Happy Child Programme in Brazil

Review of Development Economics, EarlyView.
ABSTRACT This paper adds to the growing evidence on the impacts of early childhood development (ECD) programming by examining one of the world's largest home visitation programmes, the Happy Child Programme in Brazil, and its impacts on child vaccination and preventable death rates.
Raquel Tebaldi, Franziska Gassmann, Bruno Martorano   +2 more
wiley   +1 more source

Hepatitis B in Organ Transplantation—Current Evidence and Clinical Gaps

Transplant Infectious Disease, EarlyView.
ABSTRACT Over the past several decades there have been significant advances in nucleos(t)ide analogue (NA) antiviral therapy for hepatitis B virus (HBV) and global expansion of primary prevention through immunization. Despite this, HBV remains a leading cause of chronic liver disease globally, affecting over 250 million people.
Oscar A. Fernandez‐Garcia, Britta L. Hirsch, Irene A. Abela, Karen E. Doucette   +3 more
wiley   +1 more source

Viral Hepatitis A, B and C in Roraima, Brazilian Amazon: Epidemiological and Serological Profile, 2012–2023

Tropical Medicine &International Health, EarlyView.
ABSTRACT Introduction Viral hepatitis remains a major global public health challenge, with heterogeneous epidemiological patterns across geographic and socioeconomic contexts. In the Brazilian Amazon, evidence remains limited, particularly regarding long‐term trends.
Jamilla Karla Corrêa Reis, Katrini Guidolini Martinelli, Flávia Freitas de Oliveira Bonfim, Cícera Raquel Feitosa, Bianca Jorge Sequeira, Livia Melo Villar, Vanessa Salete de Paula   +6 more
wiley   +1 more source

Assessing the financial resources required to establish convalescent plasma collection programmes across Europe in response to a pandemic

Transfusion, EarlyView.
Abstract Background During the COVID‐19 pandemic, convalescent plasma (CP) was investigated as a potential treatment. We assess the financial resources required to implement a COVID‐19 CP (CCP) programme and provide recommendations on how best to prepare for collection and use of CP in future pandemics.
Elizabeth A. Stokes, Abigail A. Lamikanra, David J. Roberts, Lise J. Estcourt, Pierre Tiberghien, Jose Leal   +5 more
wiley   +1 more source

How does a national blood operator detect early infectious disease signals affecting blood and cellular therapy product safety and sufficiency?

Transfusion, EarlyView.
Abstract Background Public access to up‐to‐date information on infectious diseases and outbreaks has grown rapidly with the advent of artificial intelligence platforms. While this information can improve patient care and support research, the sheer volume of available data coupled with the challenge of identifying misinformation and disinformation can ...
Leisa Bruneau, Carmen L. Charlton, Sandra Ramirez‐Arcos, Dilini Kumaran, David Allan, Olivia Norman, Matthew Seftel, Evan M. Bloch, Chantale Pambrun, Sheila F. O'Brien, Cynthia Cranney, Steven J. Drews   +11 more
wiley   +1 more source

SARS‐CoV‐2 targets mitochondria, exacerbating COVID‐19 pneumonia

The Journal of Physiology, EarlyView.
Abstract figure legend Following entry into airway epithelial cells (AECs), SARS‐CoV‐2 releases its single‐stranded RNA into the cytoplasm, where it is translated into viral proteins. Several of these viral proteins localize to mitochondria and interact with key mitochondrial components.
Danchen Wu, Asish Dasgupta, Jaskaran Singh Hora, Kuang‐Hueih Chen, Arinjay Banerjee, Stephen L. Archer   +5 more
wiley   +1 more source

Therapeutic, preventive, and pathogenetic advances in viral hepatitis. [PDF]

Front Cell Infect Microbiol
Jiang H, Zhang YF, Zhang RC, Xing YN.
europepmc   +1 more source

Plant‐Derived Probiotics From Fermented Foods: Current Evidence on Antiviral Mechanisms and Gut–Lung Axis Modulation

Food Frontiers, Volume 7, Issue 6, November 2026.
Plant‐derived probiotics from fermented foods exert anti‐respiratory virus effects via immune regulation, antiviral metabolites, and gut–lung axis, highlighting their advantages, key technologies, and application prospects. ABSTRACT Respiratory viral infections represent a major global public health threat, causing widespread morbidity, mortality, and ...
Yinghao Xing, Yaoyuan Hu, Yingying Ma, Peng Yao, Jingjing Jiang, Jiao Guo, Shuangmei Liu   +6 more
wiley   +1 more source

VACCINATION STATUS OF PATIENTS WITH CHRONIC LIVER DISEASE FOLLOWED UP AT A REFERENCE CENTER IN BRAZIL. [PDF]

Arq Gastroenterol
Neiva MEC, Ferraz MLG, Gama RA, Silva AEB.   +3 more
europepmc   +1 more source

Plasmepsins as Antimalarial Drug Targets—Then, Now, and the Future

Medicinal Research Reviews, Volume 46, Issue 6, Page 1574-1602, November 2026.
ABSTRACT Malaria is a devastating disease caused by Plasmodium parasites. Plasmodium parasites express ten cathepsin D‐like aspartyl proteases, called plasmepsins (PMs). These PMs have diverse roles fulfill diverse functions throughout the parasite's lifecycle, though several exhibit functional redundancies. Among them, PMV, PMIV, and PMX are essential
Brad E. Sleebs
wiley   +1 more source